NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors. Journal of Cellular BiochemistryJ. Cell. Biochem., 107(5), 908 - 916.
(2009). NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target. Current Drug TargetsCurr. Drug Targets, 10(1), 9 - 19.
(2009). Neuropeptide Y Y1 receptor antagonism increases bone mass in mice. BoneBone, 51(1), 8 - 16.
(2012). Neuropeptide y modulates fracture healing through Y1 receptor signaling. Journal of Orthopaedic Research, 31(10), 1570 - 1578.
(2013).